ASHLEY FEATHERSTON: Open Payments
NPI 1144836347 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,372 in 78 payments from 15 companies in 2025. Trend: 2023 $1,762 · 2024 $1,723 · 2025 $1,372
Food & beverage: $1,372
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $343 |
| Novartis Pharmaceuticals Corporation | 13 | $214 |
| SpringWorks Therapeutics, Inc. | 10 | $185 |
| PFIZER INC. | 16 | $159 |
| Janssen Scientific Affairs, LLC | 1 | $90 |
| Lilly USA, LLC | 1 | $90 |
| Amgen Inc. | 2 | $48 |
| Alexion Pharmaceuticals, Inc. | 2 | $47 |
| Lundbeck LLC | 2 | $40 |
| Neurocrine BioSciences, Inc. | 2 | $35 |
Products named: KESIMPTA, NURTEC ODT, GOMEKLI, UBRELVY, QULIPTA, TREMFYA, ZEPBOUND, BOTOX.
Industry payments across AR — which companies pay providers there.
